Eye Diseases, Hereditary Clinical Trial
Official title:
Fundus Changes in the Microphthalmy Eyes
Verified date | December 2008 |
Source | Hospital de Olhos Sadalla Amin Ghanem |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Observational |
The goal is to describe the fundamental aspects of fundoscopic eye in patients with microphthalmia
Status | Completed |
Enrollment | 3 |
Est. completion date | October 2008 |
Est. primary completion date | September 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 10 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of microphthalmia Exclusion Criteria: - Eyes larger than 18mm |
Observational Model: Case-Only, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hospital de Olhos Sadalla Amin Ghanem |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03872479 -
Single Ascending Dose Study in Participants With LCA10
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04123626 -
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
|
Phase 1/Phase 2 | |
Completed |
NCT01727973 -
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
|
Phase 1/Phase 2 | |
Completed |
NCT02946879 -
Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)
|
||
Terminated |
NCT03913130 -
Extension Study to Study PQ-110-001 (NCT03140969)
|
Phase 1/Phase 2 | |
Completed |
NCT03780257 -
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04765345 -
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F
|
||
Recruiting |
NCT05573984 -
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
|
||
Recruiting |
NCT02203682 -
Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy
|
Phase 2 | |
Completed |
NCT04945772 -
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
|
Phase 2 | |
Enrolling by invitation |
NCT06162585 -
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
|
||
Active, not recruiting |
NCT05158296 -
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)
|
Phase 2/Phase 3 | |
Completed |
NCT03396042 -
Natural History Study of CEP290-Related Retinal Degeneration
|
||
Terminated |
NCT05176717 -
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03913143 -
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
|
Phase 2/Phase 3 |